• Romanco Appoints Joint Managing Director of Romanco Innojet contractpharma
    August 05, 2020
    ​Romaco Holding GmbH has appointed Michael Van den Bossche as managing director of Romaco Innojet. In his new role he will be responsible for sales, laboratory, customer service and product management.
  • Zuellig Pharma appoints John Graham as new CEO prnasia
    July 14, 2020
    Zuellig Pharma, a leading healthcare services provider in Asia, announces the appointment of John Graham as its new CEO. John will run the US$13 billion business and lead the team across 13 markets in Asia.
  • Dan Furrer appointed as Head of Corporate Marketing firstwordpharma
    March 07, 2019
    Neuraxpharm Group, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces the appointment of Dan Furrer as Head of Corporate Marketing.
  • Scancell appoints Head of Research and Head of Manufacturing firstwordpharma
    January 22, 2019
    Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer, today announces the appointment of Dr Samantha Paston as Head of Research and Dr Adrian Parry as Head of Manufacturing.
  • Scancell appoints Head of Research and Head of Manufacturing firstwordpharma
    January 22, 2019
    Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer, today announces the appointment of Dr Samantha Paston as Head of Research and Dr Adrian Parry as Head of Manufacturing.
  • Immunocore appoints David Berman as R&D chief firstwordpharma
    January 16, 2019
    Prior to joining Immunocore, Berman served as senior vice president and head of AstraZeneca's immuno-oncology franchise, holding responsibility for the strategy and execution of the drugmaker's late-stage immuno-oncology programme.
  • Immunocore appoints David Berman as R&D chief firstwordpharma
    January 16, 2019
    Prior to joining Immunocore, Berman served as senior vice president and head of AstraZeneca's immuno-oncology franchise, holding responsibility for the strategy and execution of the drugmaker's late-stage immuno-oncology programme.
  • ALK appoints new Head of Product Supply firstwordpharma
    January 13, 2019
    Carsten Hellmann, President & CEO, said: "Christian's experience and leadership qualities make him ideally suited to his new role and I would like to congratulate him on his appointment and welcome him as a member of ALK's management team, where his exper
  • ALK appoints new Head of Product Supply firstwordpharma
    January 13, 2019
    Carsten Hellmann, President & CEO, said: "Christian's experience and leadership qualities make him ideally suited to his new role and I would like to congratulate him on his appointment and welcome him as a member of ALK's management team, where his exper
  • Rockwell Medical, Inc. Appoints New Vice President, Marketing firstwordpharma
    December 04, 2018
    Rockwell Medical, Inc. (NASDAQ: RMTI) (the "Company" or "Rockwell Medical") today announced that Charlie Shiner has been appointed Vice President, Marketing, effective immediately. Mr. Shiner will report to Stuart Paul, President & Chief Executive Officer
PharmaSources Customer Service